Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4133)
All Articles published online
|
Nov 7, 2011 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang L, Wu YD, Li P, Tu J, Niu YL, Xu CM, Zhang ST. Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(41): 4572-4580 [PMID: 22147962 DOI: 10.3748/wjg.v17.i41.4572] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i41/4572.htm |
| Number | Citing Articles |
| 1 |
FENG-JUN GUO, JING-YAN TIAN, YUE-MEI JIN, LING WANG, RUI-QI YANG, MAN-HUA CUI. Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells. Molecular Medicine Reports 2015; 11(1): 59 doi: 10.3892/mmr.2014.2732
|
| 2 |
Jente van Staalduinen, Martine Frouws, Marlies Reimers, Esther Bastiaannet, Myrthe P P van Herk-Sukel, Valery Lemmens, Wobbe O de Steur, Henk H Hartgrink, Cornelis J H van de Velde, Gerrit-Jan Liefers. The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients. British Journal of Cancer 2016; 114(9): 1053 doi: 10.1038/bjc.2016.65
|
| 3 |
Yi Zhou, Hui Peng, Zhimin Liu, Ke K. Zhang, Chelsea Jendrusch, Madeline Drake, Yi Hao, Linglin Xie. Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero. Laboratory Investigation 2019; 99(2): 244 doi: 10.1038/s41374-018-0144-2
|
| 4 |
Peng Li, Rui Cheng, Shutian Zhang. Aspirin and esophageal squamous cell carcinoma: bedside to bench. Chinese Medical Journal 2014; 127(7): 1365 doi: 10.3760/cma.j.issn.0366-6999.20140227
|
| 5 |
Meysam Moghbeli, Mohammad Reza Abbaszadegan, Moein Farshchian, Mehdi Montazer, Reza Raeisossadati, Abbas Abdollahi, Mohammad Mahdi Forghanifard. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0516-9
|
| 6 |
Tomoyuki Okumura, Hirohumi Kojima, Tetsuji Yamaguchi, Yutaka Shimada. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy. Current Human Cell Research and Applications 2018; : 49 doi: 10.1007/978-981-10-6469-2_3
|
| 7 |
YANG LIN, MANHUA CUI, TIANMIN XU, WEI YU, LIHUI ZHANG. Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells. Molecular Medicine Reports 2014; 9(6): 2499 doi: 10.3892/mmr.2014.2131
|
| 8 |
Ameneh Elikaei, Hossein Vazini, Fatemeh Javani Jouni, Jaber Zafari. Investigating Cytotoxic Effects of Juniperus Excelsa Extract on Esophageal Cancer Cell Line KYSE-30 and Normal Fibroblast Cell Line HU02. Medical Laboratory Journal 2019; 13(5): 13 doi: 10.29252/mlj.13.5.13
|
| 9 |
Gianluca Farrugia, Rena Balzan. The Proapoptotic Effect of Traditional and Novel Nonsteroidal Anti-Inflammatory Drugs in Mammalian and Yeast Cells. Oxidative Medicine and Cellular Longevity 2013; 2013: 1 doi: 10.1155/2013/504230
|
| 10 |
Lei Yang, Jun-ya Zhu, Jian-guo Zhang, Bo-jun Bao, Cheng-qi Guan, Xiao-jing Yang, Yan-hua Liu, Yue-jiao Huang, Run-zhou Ni, Li-li Ji. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression. Tumor Biology 2016; 37(3): 4115 doi: 10.1007/s13277-015-4263-8
|
| 11 |
Ying Shao, Peng Li, Sheng-tao Zhu, Ji-ping Yue, Xiao-jun Ji, Zhen He, Dan Ma, Li Wang, Yong-jun Wang, Ye Zong, Yong-dong Wu, Shu-tian Zhang, Yifeng Zhou. Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma. PLOS ONE 2015; 10(11): e0140642 doi: 10.1371/journal.pone.0140642
|
| 12 |
Shu Zhang, Xiaojing Yang, Hui Shi, Mei Li, Qun Xue, Hanru Ren, Li Yao, Xueyu Chen, Jianguo Zhang, Huijie Wang. Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma. Journal of Molecular Histology 2014; 45(3): 283 doi: 10.1007/s10735-014-9566-3
|
| 13 |
Jianguo Zhang, Junya Zhu, Lei Yang, Chengqi Guan, Runzhou Ni, Yuchan Wang, Lili Ji, Ye Tian. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression. Tumor Biology 2015; 36(9): 6701 doi: 10.1007/s13277-015-3354-x
|
| 14 |
M. Li, X. Yang, H. Shi, H. Ren, X. Chen, S. Zhang, J. Zhu, J. Zhang. Downregulated Expression of the Cyclase-associated Protein 1 (CAP1) Reduces Migration in Esophageal Squamous Cell Carcinoma. Japanese Journal of Clinical Oncology 2013; 43(9): 856 doi: 10.1093/jjco/hyt093
|
| 15 |
Lucia Laura Policastro, Irene Laura Ibañez, Cintia Notcovich, Hebe Alicia Duran, Osvaldo Luis Podhajcer. The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy. Antioxidants & Redox Signaling 2013; 19(8): 854 doi: 10.1089/ars.2011.4367
|
| 16 |
Nikolaos G. Nikitakis, Monica Pentenero, Maria Georgaki, Catherine F. Poh, Douglas E. Peterson, Paul Edwards, Mark Lingen, John J. Sauk. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2018; 125(6): 650 doi: 10.1016/j.oooo.2018.03.012
|
| 17 |
Yanting Xu, Jiangtu He, Yue Wang, Xinyi Zhu, Qiuhui Pan, Qiuling Xie, Fenyong Sun. miR‐889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP. FEBS Letters 2015; 589(10): 1127 doi: 10.1016/j.febslet.2015.03.027
|
| 18 |
Debasish Basak, Mohammad Nasir Uddin, Jake Hancock. The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC). Cancers 2020; 12(11): 3336 doi: 10.3390/cancers12113336
|